| No | DFS | OS | |
| n (%) | p Value | p Value | |
| Sex | |||
| Male | 70 (67) | 0.27 | 0.88 |
| Female | 34 (33) | ||
| Histological grade | |||
| Well | 3 (3) | 0.19 | 0.02 |
| Moderate | 33 (32) | ||
| Poor | 68 (65) | ||
| Lauren classification | |||
| Intestinal | 88 (85) | 0.009 | 0.008 |
| Diffuse | 16 (15) | ||
| Depth of wall invasion (T stage) | |||
| pT1 | 16 (15) | 0.001 | 0.006 |
| pT2 | 60 (58) | ||
| pT3 | 25 (24) | ||
| pT4 | 3 (3) | ||
| Lymph node metastasis | |||
| No | 46 (44) | 0.001 | 0.03 |
| Yes | 58 (56) | ||
| Distant metastasis | |||
| No | 94 (90) | 0.001 | 0.001 |
| Yes | 10 (10) | ||
| Resection margin | |||
| R0 vs | 97 (93) | 0.01 | 0.03 |
| R1+R2 | 7 (7) | ||
| Stage (UICC) | |||
| I | 37 (36) | 0.001 | 0.006 |
| II+III+IV | 67 (64) | ||
| TROP2 overexpression | |||
| Yes | 58 (44) | 0.10 | 0.97 |
| No | 46 (56) |
DFS, disease-free survival; OS, overall survival.